John A. Joyce

681 total citations
8 papers, 544 citations indexed

About

John A. Joyce is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, John A. Joyce has authored 8 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in John A. Joyce's work include Glycosylation and Glycoproteins Research (3 papers), Neuroscience and Neuropharmacology Research (3 papers) and Lysosomal Storage Disorders Research (3 papers). John A. Joyce is often cited by papers focused on Glycosylation and Glycoproteins Research (3 papers), Neuroscience and Neuropharmacology Research (3 papers) and Lysosomal Storage Disorders Research (3 papers). John A. Joyce collaborates with scholars based in United States, Canada and Germany. John A. Joyce's co-authors include Nigel S. Bamford, Siobhan Robinson, Charles K. Meshul, Cynthia Moore, Richard D. Palmiter, Michael S. Levine, Carlos Cepeda, Audrey Gray, Michael R. Hayden and Mark S. Shearman and has published in prestigious journals such as Neuron, Journal of Neuroscience and PLoS ONE.

In The Last Decade

John A. Joyce

8 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Joyce United States 8 346 257 163 93 78 8 544
Kevin Chen United States 10 267 0.8× 224 0.9× 157 1.0× 35 0.4× 36 0.5× 13 570
M. G. FORNARETTO Italy 6 411 1.2× 271 1.1× 105 0.6× 77 0.8× 27 0.3× 10 600
Laura Aldegheri Italy 10 289 0.8× 285 1.1× 37 0.2× 74 0.8× 25 0.3× 14 487
Roberto Pattarini Italy 11 285 0.8× 214 0.8× 51 0.3× 43 0.5× 45 0.6× 12 464
Hervé Maurin Belgium 11 180 0.5× 164 0.6× 37 0.2× 34 0.4× 233 3.0× 18 463
Peter Jeffrey Conn United States 6 407 1.2× 268 1.0× 36 0.2× 83 0.9× 65 0.8× 7 510
Leann P. Quinn United Kingdom 9 203 0.6× 167 0.6× 80 0.5× 41 0.4× 48 0.6× 11 368
Isabel Espadas Spain 11 345 1.0× 213 0.8× 172 1.1× 92 1.0× 97 1.2× 16 610
Erik T. Dustrude United States 14 323 0.9× 332 1.3× 61 0.4× 68 0.7× 235 3.0× 23 596
Shaolin Liu United States 15 363 1.0× 126 0.5× 38 0.2× 82 0.9× 26 0.3× 24 638

Countries citing papers authored by John A. Joyce

Since Specialization
Citations

This map shows the geographic impact of John A. Joyce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Joyce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Joyce more than expected).

Fields of papers citing papers by John A. Joyce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Joyce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Joyce. The network helps show where John A. Joyce may publish in the future.

Co-authorship network of co-authors of John A. Joyce

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Joyce. A scholar is included among the top collaborators of John A. Joyce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Joyce. John A. Joyce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Dillon, Gregory M., Jaclyn L. Henderson, John A. Joyce, et al.. (2020). Acute inhibition of the CNS-specific kinase TTBK1 significantly lowers tau phosphorylation at several disease relevant sites. PLoS ONE. 15(4). e0228771–e0228771. 16 indexed citations
2.
Graham, Danielle, Audrey Gray, John A. Joyce, et al.. (2013). Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy. Neuropharmacology. 79. 307–313. 89 indexed citations
3.
Cameron, Andrew, John A. Joyce, Audrey Gray, et al.. (2013). Generation and characterization of a rabbit monoclonal antibody site‐specific for tau O‐GlcNAcylated at serine 400. FEBS Letters. 587(22). 3722–3728. 28 indexed citations
4.
Hering, Heike, Danielle Graham, Audrey Gray, et al.. (2013). Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer’s disease and tauopathies. Molecular Neurodegeneration. 8(S1). 7 indexed citations
5.
Joshi, Prasad, Véronique M. André, Damian M. Cummings, et al.. (2009). Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease. Journal of Neuroscience. 29(8). 2414–2427. 141 indexed citations
6.
Bamford, Nigel S., Hui Zhang, John A. Joyce, et al.. (2008). Repeated Exposure to Methamphetamine Causes Long-Lasting Presynaptic Corticostriatal Depression that Is Renormalized with Drug Readministration. Neuron. 58(1). 89–103. 78 indexed citations
7.
Gospe, Sídney M., John A. Joyce, Joseph R. Siebert, Rhona M. Jack, & Kent E. Pinkerton. (2008). Exposure to environmental tobacco smoke during pregnancy in rats yields less effect on indices of brain cell number and size than does postnatal exposure. Reproductive Toxicology. 27(1). 22–27. 9 indexed citations
8.
Bamford, Nigel S., Siobhan Robinson, Richard D. Palmiter, et al.. (2004). Dopamine Modulates Release from Corticostriatal Terminals. Journal of Neuroscience. 24(43). 9541–9552. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026